Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/07/2003 | US20030146113 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
08/07/2003 | US20030146111 Enzymatic-electrochemical measuring device |
08/07/2003 | US20030146110 Determination glucose concentration in blood |
08/07/2003 | US20030146095 Methods for the electronic, Homogeneous assembly and fabrication of devices |
08/07/2003 | US20030146091 Multiaperture sample positioning and analysis system |
08/07/2003 | US20030145987 Measuring the in situ static formation temperature |
08/07/2003 | US20030145696 Apparatus for machining composite material test specimens |
08/07/2003 | US20030145647 System and method for measuring oil condition in large engines |
08/07/2003 | US20030145646 Multi-parameter monitoring system |
08/07/2003 | US20030145644 Self-calibrating carbon monoxide detector and method |
08/07/2003 | US20030145394 Helium-neon excitable reticulocyte dyes derivable from halolepidines |
08/07/2003 | DE20307858U1 Wine tasting device for blind tasting comprises container for holding bottles and a display device showing contents but covered by removable cover |
08/07/2003 | DE19932958C2 Vorrichtung zur Bindung von Molekülen, Molekülgruppen, Molekülteilen und/oder Zellen A device for binding molecules, molecular groups, molecular parts and / or cells |
08/07/2003 | DE10203816C1 Sensorfeld zur Feuchtemessung Field sensor for humidity measurement |
08/07/2003 | CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
08/07/2003 | CA2474982A1 Computer systems and methods for identifying genes and determining pathways associated with traits |
08/07/2003 | CA2474955A1 A method and device to ascertain physical characteristics of porous media |
08/07/2003 | CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
08/07/2003 | CA2474788A1 Compositions and methods for modulating connexin hemichannels |
08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
08/07/2003 | CA2474724A1 Process for detecting predisposition to a cardiovascular disease |
08/07/2003 | CA2474689A1 Drugs ameliorating circadian rhythum disorder |
08/07/2003 | CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/07/2003 | CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them |
08/07/2003 | CA2474562A1 A guided mode resonant filter biosensor using a linear grating surface structure |
08/07/2003 | CA2474482A1 Methods for placing, accepting, and filling orders for products and services |
08/07/2003 | CA2474469A1 Chemical proteomics |
08/07/2003 | CA2474458A1 Method for detecting microorganisms |
08/07/2003 | CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
08/07/2003 | CA2474432A1 A label-free high throughput optical technique for detecting biomolecular interactions |
08/07/2003 | CA2474339A1 Multiple virus replicon culture systems |
08/07/2003 | CA2474316A1 Kappa-pviia-related conotoxins as organ protectants |
08/07/2003 | CA2474091A1 Method of fixing biomolecule to carrier |
08/07/2003 | CA2474006A1 Variants of the alpha 1 subunit of human ampk |
08/07/2003 | CA2473994A1 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
08/07/2003 | CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase |
08/07/2003 | CA2473984A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
08/07/2003 | CA2473810A1 Fgfr agonists |
08/07/2003 | CA2473134A1 Method for determining the dissolution rate of a solid water treatment product |
08/07/2003 | CA2473128A1 Genetic polymorphisms in the preprotachykinin gene |
08/07/2003 | CA2472153A1 Method and test kit for demonstrating genetic identity |
08/07/2003 | CA2471661A1 Molecular hepatotoxicology modeling |
08/07/2003 | CA2469738A1 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
08/07/2003 | CA2462216A1 Antigen panels and methods of using the same |
08/07/2003 | CA2447892A1 Complement mediated assays for in vivo and in vitro methods |
08/07/2003 | CA2438112A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
08/06/2003 | EP1333285A1 Biochemical analysis unit and method for producing thereof |
08/06/2003 | EP1333284A1 Method for conducting receptor-ligand association reactions |
08/06/2003 | EP1333283A2 Method and reactor for conducting receptor-ligand association reactions |
08/06/2003 | EP1333282A2 Method and reactor for conducting receptor-ligand association reactions |
08/06/2003 | EP1333281A2 Method and reactor for conducting receptor-ligand association reactions |
08/06/2003 | EP1333280A1 Reagent and method for detecting biopolymers |
08/06/2003 | EP1333279A2 Method for carrying out electric measurements of biological membranes |
08/06/2003 | EP1333278A1 Methods for monitoring and prognosis of disease course of gastrointestinal tumors |
08/06/2003 | EP1333274A2 Up-converting reporters for biological and other assays using laser excitation techniques |
08/06/2003 | EP1333100A2 RET oligonucleotide microchip and method for detecting hereditary cancer employing same |
08/06/2003 | EP1333096A1 Method to identify gene function using phage display screening |
08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
08/06/2003 | EP1333093A2 Human muscle nad: arginine adpribosyltransferase |
08/06/2003 | EP1333035A2 Growth differentiation factor-8 |
08/06/2003 | EP1333023A1 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites |
08/06/2003 | EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
08/06/2003 | EP1332513A2 Detecting polymers and polymer fragments |
08/06/2003 | EP1332396A2 Cytological imaging systems and methods |
08/06/2003 | EP1332373A1 Method of measuring platelet activation |
08/06/2003 | EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
08/06/2003 | EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
08/06/2003 | EP1332370A2 A method for the quantification of carbohydrates |
08/06/2003 | EP1332369A1 Detection of infectious agents using antigen mimics |
08/06/2003 | EP1332368A2 Methods for detecting the efficacy of anticancer treatments |
08/06/2003 | EP1332367A2 Detection of ovarian cancer |
08/06/2003 | EP1332366A1 Methods for the treatment of cellular proliferative disorders |
08/06/2003 | EP1332365A2 Method and test kit for detecting analytes in a sample |
08/06/2003 | EP1332363A1 Detection of neurodegenerative disorders |
08/06/2003 | EP1332362A1 Kruppel-like factor 6 (klf6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
08/06/2003 | EP1332361A2 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors |
08/06/2003 | EP1332358A1 Acid gas measuring sensors and method of making same |
08/06/2003 | EP1332357A1 Ligand based solution assay for low concentration analytes |
08/06/2003 | EP1332229A1 Method for screening agents capable of treating obesity |
08/06/2003 | EP1332226A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma |
08/06/2003 | EP1332225A2 Method of identifying abnormal immune reactions |
08/06/2003 | EP1332218A1 Differentiation-inducing substances |
08/06/2003 | EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
08/06/2003 | EP1332157A2 Prokineticin polypeptides, related compositions and methods |
08/06/2003 | EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
08/06/2003 | EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp |
08/06/2003 | EP1332153A1 Human ect2 and methods of use |
08/06/2003 | EP1332135A1 Tagging compounds and process for use in aida libraries |
08/06/2003 | EP1332007A2 Modified carbon, silicon and germanium surfaces |
08/06/2003 | EP1332000A2 Method and apparatus for delivery of submicroliter volumes onto a substrate |
08/06/2003 | EP1331996A1 Method and apparatus for gradient generation |
08/06/2003 | EP1331976A2 System and method for automated matched ion polynucleotide chromatography |
08/06/2003 | EP1331949A2 Method for inducing apoptiosis |
08/06/2003 | EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation |
08/06/2003 | EP1331930A2 Methods and compositions for regulating memory consolidation |
08/06/2003 | EP1241933A4 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
08/06/2003 | EP1237401B1 Constituent sensing system |
08/06/2003 | EP1152888A4 Magnetically responsive gel particle |
08/06/2003 | EP1101093A4 Test for oxidative stress using cell suspensions |
08/06/2003 | EP1062840A4 Apparatus and method for a custom soft-solid hearing aid |